Tau and stathmin proteins in breast cancer: A potential therapeutic target

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Breast cancer is a leading cause of death in women, with treatment failure often due to multidrug resistance (MDR).
• Malignant tumor progression and therapeutic resistance are linked to specific molecular processes.
• Stathmin and tau proteins are increasingly recognized for their role in various cancers.

Purpose of the Study:

• To review existing literature on the expression of tau protein and stathmin in breast cancer.
• To summarize the involvement of these proteins in breast cancer development and progression.
• To explore their potential role in treatment strategies and overcoming drug resistance.

Main Methods:

• Comprehensive literature search of studies on stathmin and tau protein expression in breast cancer.
• Analysis of research investigating the functional roles of stathmin and tau in cancer cell proliferation, invasion, and drug resistance.
• Synthesis of findings related to therapeutic interventions targeting these proteins.

Main Results:

• Stathmin and tau proteins are upregulated in numerous human malignant tumors, including breast cancer.
• These proteins promote cancer cell reproduction, infiltration, and contribute to multidrug resistance (MDR).
• Their overexpression is associated with increased incidence and progression of malignancies.

Conclusions:

• Stathmin and tau are key molecular players in breast cancer progression and therapeutic resistance.
• Targeting stathmin and tau presents a promising avenue for novel molecularly targeted therapies.
• Further research into these proteins is essential for improving breast cancer treatment outcomes.